1-1 of 1
Jonas Fullin
Close
Sort by
Journal Articles

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Roman R. Schimmer, Larisa V. Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M. Stolz, Jan Mueller, Francisco Caiado, Kari J. Kurppa, Benjamin L. Ebert, Markus G. Manz, Steffen Boettcher
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3201–3206.
https://doi.org/10.1182/bloodadvances.2021005859
Published: 2022
Includes: Supplemental data